Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Generic Medicine Market Growth (Status and Outlook) 2022-2028

  • LP 4833389
  • 124 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Generic Medicine will have significant change from previous year. According to our (LP Information) latest study, the global Generic Medicine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Generic Medicine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Generic Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Generic Medicine market, reaching US$ million by the year 2028. As for the Europe Generic Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Generic Medicine players cover Teva, Novartis - Sandoz, Mylan, and Sun Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Generic Medicine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Simple Generic Drugs

Super Generic Drugs

Biosimilars

By Application:

CNS

Cardiovascular

Respiratory

Rheumatology

Diabetes

Oncology

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

CNS

Cardiovascular

Respiratory

Rheumatology

Diabetes

Oncology

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Teva

Novartis - Sandoz

Mylan

Sun Pharmaceutical

Aspen

Fresenius Kabi

Pfizer (Hospira)

Sanofi

Aurobindo

Lupin

Dr. Reddy's

Apotex

Cipla

ENDO (Par Pharmaceutical)

Stada Arzneimittel

Krka Group

Nichi-Iko Pharmaceutical

Valeant

Zydus Cadila

Hikma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Generic Medicine Market Size 2017-2028

2.1.2 Generic Medicine Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Generic Medicine Segment by Type

2.2.1 Simple Generic Drugs

2.2.2 Super Generic Drugs

2.2.3 Biosimilars

2.2.4 By Application:

2.2.5 CNS

2.2.6 Cardiovascular

2.2.7 Respiratory

2.2.8 Rheumatology

2.2.9 Diabetes

2.2.10 Oncology

2.3 Generic Medicine Market Size by Type

2.3.1 Generic Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Generic Medicine Market Size Market Share by Type (2017-2022)

2.4 Generic Medicine Segment by Application

2.4.1 CNS

2.4.2 Cardiovascular

2.4.3 Respiratory

2.4.4 Rheumatology

2.4.5 Diabetes

2.4.6 Oncology

2.4.7 Others

2.5 Generic Medicine Market Size by Application

2.5.1 Generic Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Generic Medicine Market Size Market Share by Application (2017-2022)

3 Generic Medicine Market Size by Player

3.1 Generic Medicine Market Size Market Share by Players

3.1.1 Global Generic Medicine Revenue by Players (2020-2022)

3.1.2 Global Generic Medicine Revenue Market Share by Players (2020-2022)

3.2 Global Generic Medicine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Generic Medicine by Regions

4.1 Generic Medicine Market Size by Regions (2017-2022)

4.2 Americas Generic Medicine Market Size Growth (2017-2022)

4.3 APAC Generic Medicine Market Size Growth (2017-2022)

4.4 Europe Generic Medicine Market Size Growth (2017-2022)

4.5 Middle East & Africa Generic Medicine Market Size Growth (2017-2022)

5 Americas

5.1 Americas Generic Medicine Market Size by Country (2017-2022)

5.2 Americas Generic Medicine Market Size by Type (2017-2022)

5.3 Americas Generic Medicine Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Generic Medicine Market Size by Region (2017-2022)

6.2 APAC Generic Medicine Market Size by Type (2017-2022)

6.3 APAC Generic Medicine Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Generic Medicine by Country (2017-2022)

7.2 Europe Generic Medicine Market Size by Type (2017-2022)

7.3 Europe Generic Medicine Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Generic Medicine by Region (2017-2022)

8.2 Middle East & Africa Generic Medicine Market Size by Type (2017-2022)

8.3 Middle East & Africa Generic Medicine Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Generic Medicine Market Forecast

10.1 Global Generic Medicine Forecast by Regions (2023-2028)

10.1.1 Global Generic Medicine Forecast by Regions (2023-2028)

10.1.2 Americas Generic Medicine Forecast

10.1.3 APAC Generic Medicine Forecast

10.1.4 Europe Generic Medicine Forecast

10.1.5 Middle East & Africa Generic Medicine Forecast

10.2 Americas Generic Medicine Forecast by Country (2023-2028)

10.2.1 United States Generic Medicine Market Forecast

10.2.2 Canada Generic Medicine Market Forecast

10.2.3 Mexico Generic Medicine Market Forecast

10.2.4 Brazil Generic Medicine Market Forecast

10.3 APAC Generic Medicine Forecast by Region (2023-2028)

10.3.1 China Generic Medicine Market Forecast

10.3.2 Japan Generic Medicine Market Forecast

10.3.3 Korea Generic Medicine Market Forecast

10.3.4 Southeast Asia Generic Medicine Market Forecast

10.3.5 India Generic Medicine Market Forecast

10.3.6 Australia Generic Medicine Market Forecast

10.4 Europe Generic Medicine Forecast by Country (2023-2028)

10.4.1 Germany Generic Medicine Market Forecast

10.4.2 France Generic Medicine Market Forecast

10.4.3 UK Generic Medicine Market Forecast

10.4.4 Italy Generic Medicine Market Forecast

10.4.5 Russia Generic Medicine Market Forecast

10.5 Middle East & Africa Generic Medicine Forecast by Region (2023-2028)

10.5.1 Egypt Generic Medicine Market Forecast

10.5.2 South Africa Generic Medicine Market Forecast

10.5.3 Israel Generic Medicine Market Forecast

10.5.4 Turkey Generic Medicine Market Forecast

10.5.5 GCC Countries Generic Medicine Market Forecast

10.6 Global Generic Medicine Forecast by Type (2023-2028)

10.7 Global Generic Medicine Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Teva

11.1.1 Teva Company Information

11.1.2 Teva Generic Medicine Product Offered

11.1.3 Teva Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Teva Main Business Overview

11.1.5 Teva Latest Developments

11.2 Novartis - Sandoz

11.2.1 Novartis - Sandoz Company Information

11.2.2 Novartis - Sandoz Generic Medicine Product Offered

11.2.3 Novartis - Sandoz Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis - Sandoz Main Business Overview

11.2.5 Novartis - Sandoz Latest Developments

11.3 Mylan

11.3.1 Mylan Company Information

11.3.2 Mylan Generic Medicine Product Offered

11.3.3 Mylan Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Mylan Main Business Overview

11.3.5 Mylan Latest Developments

11.4 Sun Pharmaceutical

11.4.1 Sun Pharmaceutical Company Information

11.4.2 Sun Pharmaceutical Generic Medicine Product Offered

11.4.3 Sun Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Sun Pharmaceutical Main Business Overview

11.4.5 Sun Pharmaceutical Latest Developments

11.5 Aspen

11.5.1 Aspen Company Information

11.5.2 Aspen Generic Medicine Product Offered

11.5.3 Aspen Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Aspen Main Business Overview

11.5.5 Aspen Latest Developments

11.6 Fresenius Kabi

11.6.1 Fresenius Kabi Company Information

11.6.2 Fresenius Kabi Generic Medicine Product Offered

11.6.3 Fresenius Kabi Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Fresenius Kabi Main Business Overview

11.6.5 Fresenius Kabi Latest Developments

11.7 Pfizer (Hospira)

11.7.1 Pfizer (Hospira) Company Information

11.7.2 Pfizer (Hospira) Generic Medicine Product Offered

11.7.3 Pfizer (Hospira) Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Pfizer (Hospira) Main Business Overview

11.7.5 Pfizer (Hospira) Latest Developments

11.8 Sanofi

11.8.1 Sanofi Company Information

11.8.2 Sanofi Generic Medicine Product Offered

11.8.3 Sanofi Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Sanofi Main Business Overview

11.8.5 Sanofi Latest Developments

11.9 Aurobindo

11.9.1 Aurobindo Company Information

11.9.2 Aurobindo Generic Medicine Product Offered

11.9.3 Aurobindo Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Aurobindo Main Business Overview

11.9.5 Aurobindo Latest Developments

11.10 Lupin

11.10.1 Lupin Company Information

11.10.2 Lupin Generic Medicine Product Offered

11.10.3 Lupin Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Lupin Main Business Overview

11.10.5 Lupin Latest Developments

11.11 Dr. Reddy's

11.11.1 Dr. Reddy's Company Information

11.11.2 Dr. Reddy's Generic Medicine Product Offered

11.11.3 Dr. Reddy's Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Dr. Reddy's Main Business Overview

11.11.5 Dr. Reddy's Latest Developments

11.12 Apotex

11.12.1 Apotex Company Information

11.12.2 Apotex Generic Medicine Product Offered

11.12.3 Apotex Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Apotex Main Business Overview

11.12.5 Apotex Latest Developments

11.13 Cipla

11.13.1 Cipla Company Information

11.13.2 Cipla Generic Medicine Product Offered

11.13.3 Cipla Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Cipla Main Business Overview

11.13.5 Cipla Latest Developments

11.14 ENDO (Par Pharmaceutical)

11.14.1 ENDO (Par Pharmaceutical) Company Information

11.14.2 ENDO (Par Pharmaceutical) Generic Medicine Product Offered

11.14.3 ENDO (Par Pharmaceutical) Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 ENDO (Par Pharmaceutical) Main Business Overview

11.14.5 ENDO (Par Pharmaceutical) Latest Developments

11.15 Stada Arzneimittel

11.15.1 Stada Arzneimittel Company Information

11.15.2 Stada Arzneimittel Generic Medicine Product Offered

11.15.3 Stada Arzneimittel Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Stada Arzneimittel Main Business Overview

11.15.5 Stada Arzneimittel Latest Developments

11.16 Krka Group

11.16.1 Krka Group Company Information

11.16.2 Krka Group Generic Medicine Product Offered

11.16.3 Krka Group Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Krka Group Main Business Overview

11.16.5 Krka Group Latest Developments

11.17 Nichi-Iko Pharmaceutical

11.17.1 Nichi-Iko Pharmaceutical Company Information

11.17.2 Nichi-Iko Pharmaceutical Generic Medicine Product Offered

11.17.3 Nichi-Iko Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Nichi-Iko Pharmaceutical Main Business Overview

11.17.5 Nichi-Iko Pharmaceutical Latest Developments

11.18 Valeant

11.18.1 Valeant Company Information

11.18.2 Valeant Generic Medicine Product Offered

11.18.3 Valeant Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Valeant Main Business Overview

11.18.5 Valeant Latest Developments

11.19 Zydus Cadila

11.19.1 Zydus Cadila Company Information

11.19.2 Zydus Cadila Generic Medicine Product Offered

11.19.3 Zydus Cadila Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Zydus Cadila Main Business Overview

11.19.5 Zydus Cadila Latest Developments

11.20 Hikma

11.20.1 Hikma Company Information

11.20.2 Hikma Generic Medicine Product Offered

11.20.3 Hikma Generic Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Hikma Main Business Overview

11.20.5 Hikma Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Generic Medicine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Simple Generic Drugs

Table 3. Major Players of Super Generic Drugs

Table 4. Major Players of Biosimilars

Table 5. Major Players of By Application:

Table 6. Major Players of CNS

Table 7. Major Players of Cardiovascular

Table 8. Major Players of Respiratory

Table 9. Major Players of Rheumatology

Table 10. Major Players of Diabetes

Table 11. Major Players of Oncology

Table 12. Generic Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Generic Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 14. Global Generic Medicine Market Size Market Share by Type (2017-2022)

Table 15. Generic Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 16. Global Generic Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 17. Global Generic Medicine Market Size Market Share by Application (2017-2022)

Table 18. Global Generic Medicine Revenue by Players (2020-2022) & ($ Millions)

Table 19. Global Generic Medicine Revenue Market Share by Player (2020-2022)

Table 20. Generic Medicine Key Players Head office and Products Offered

Table 21. Generic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Generic Medicine Market Size by Regions 2017-2022 & ($ Millions)

Table 25. Global Generic Medicine Market Size Market Share by Regions (2017-2022)

Table 26. Americas Generic Medicine Market Size by Country (2017-2022) & ($ Millions)

Table 27. Americas Generic Medicine Market Size Market Share by Country (2017-2022)

Table 28. Americas Generic Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 29. Americas Generic Medicine Market Size Market Share by Type (2017-2022)

Table 30. Americas Generic Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 31. Americas Generic Medicine Market Size Market Share by Application (2017-2022)

Table 32. APAC Generic Medicine Market Size by Region (2017-2022) & ($ Millions)

Table 33. APAC Generic Medicine Market Size Market Share by Region (2017-2022)

Table 34. APAC Generic Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 35. APAC Generic Medicine Market Size Market Share by Type (2017-2022)

Table 36. APAC Generic Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 37. APAC Generic Medicine Market Size Market Share by Application (2017-2022)

Table 38. Europe Generic Medicine Market Size by Country (2017-2022) & ($ Millions)

Table 39. Europe Generic Medicine Market Size Market Share by Country (2017-2022)

Table 40. Europe Generic Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 41. Europe Generic Medicine Market Size Market Share by Type (2017-2022)

Table 42. Europe Generic Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 43. Europe Generic Medicine Market Size Market Share by Application (2017-2022)

Table 44. Middle East & Africa Generic Medicine Market Size by Region (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Generic Medicine Market Size Market Share by Region (2017-2022)

Table 46. Middle East & Africa Generic Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Generic Medicine Market Size Market Share by Type (2017-2022)

Table 48. Middle East & Africa Generic Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 49. Middle East & Africa Generic Medicine Market Size Market Share by Application (2017-2022)

Table 50. Key Market Drivers & Growth Opportunities of Generic Medicine

Table 51. Key Market Challenges & Risks of Generic Medicine

Table 52. Key Industry Trends of Generic Medicine

Table 53. Global Generic Medicine Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 54. Global Generic Medicine Market Size Market Share Forecast by Regions (2023-2028)

Table 55. Global Generic Medicine Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 56. Global Generic Medicine Market Size Market Share Forecast by Type (2023-2028)

Table 57. Global Generic Medicine Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 58. Global Generic Medicine Market Size Market Share Forecast by Application (2023-2028)

Table 59. Teva Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 60. Teva Generic Medicine Product Offered

Table 61. Teva Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Teva Main Business

Table 63. Teva Latest Developments

Table 64. Novartis - Sandoz Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 65. Novartis - Sandoz Generic Medicine Product Offered

Table 66. Novartis - Sandoz Main Business

Table 67. Novartis - Sandoz Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Novartis - Sandoz Latest Developments

Table 69. Mylan Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 70. Mylan Generic Medicine Product Offered

Table 71. Mylan Main Business

Table 72. Mylan Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Mylan Latest Developments

Table 74. Sun Pharmaceutical Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 75. Sun Pharmaceutical Generic Medicine Product Offered

Table 76. Sun Pharmaceutical Main Business

Table 77. Sun Pharmaceutical Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Sun Pharmaceutical Latest Developments

Table 79. Aspen Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 80. Aspen Generic Medicine Product Offered

Table 81. Aspen Main Business

Table 82. Aspen Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Aspen Latest Developments

Table 84. Fresenius Kabi Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 85. Fresenius Kabi Generic Medicine Product Offered

Table 86. Fresenius Kabi Main Business

Table 87. Fresenius Kabi Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Fresenius Kabi Latest Developments

Table 89. Pfizer (Hospira) Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 90. Pfizer (Hospira) Generic Medicine Product Offered

Table 91. Pfizer (Hospira) Main Business

Table 92. Pfizer (Hospira) Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Pfizer (Hospira) Latest Developments

Table 94. Sanofi Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 95. Sanofi Generic Medicine Product Offered

Table 96. Sanofi Main Business

Table 97. Sanofi Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Sanofi Latest Developments

Table 99. Aurobindo Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 100. Aurobindo Generic Medicine Product Offered

Table 101. Aurobindo Main Business

Table 102. Aurobindo Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Aurobindo Latest Developments

Table 104. Lupin Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 105. Lupin Generic Medicine Product Offered

Table 106. Lupin Main Business

Table 107. Lupin Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Lupin Latest Developments

Table 109. Dr. Reddy's Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 110. Dr. Reddy's Generic Medicine Product Offered

Table 111. Dr. Reddy's Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Dr. Reddy's Main Business

Table 113. Dr. Reddy's Latest Developments

Table 114. Apotex Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 115. Apotex Generic Medicine Product Offered

Table 116. Apotex Main Business

Table 117. Apotex Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Apotex Latest Developments

Table 119. Cipla Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 120. Cipla Generic Medicine Product Offered

Table 121. Cipla Main Business

Table 122. Cipla Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Cipla Latest Developments

Table 124. ENDO (Par Pharmaceutical) Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 125. ENDO (Par Pharmaceutical) Generic Medicine Product Offered

Table 126. ENDO (Par Pharmaceutical) Main Business

Table 127. ENDO (Par Pharmaceutical) Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. ENDO (Par Pharmaceutical) Latest Developments

Table 129. Stada Arzneimittel Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 130. Stada Arzneimittel Generic Medicine Product Offered

Table 131. Stada Arzneimittel Main Business

Table 132. Stada Arzneimittel Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Stada Arzneimittel Latest Developments

Table 134. Krka Group Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 135. Krka Group Generic Medicine Product Offered

Table 136. Krka Group Main Business

Table 137. Krka Group Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. Krka Group Latest Developments

Table 139. Nichi-Iko Pharmaceutical Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 140. Nichi-Iko Pharmaceutical Generic Medicine Product Offered

Table 141. Nichi-Iko Pharmaceutical Main Business

Table 142. Nichi-Iko Pharmaceutical Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 143. Nichi-Iko Pharmaceutical Latest Developments

Table 144. Valeant Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 145. Valeant Generic Medicine Product Offered

Table 146. Valeant Main Business

Table 147. Valeant Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 148. Valeant Latest Developments

Table 149. Zydus Cadila Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 150. Zydus Cadila Generic Medicine Product Offered

Table 151. Zydus Cadila Main Business

Table 152. Zydus Cadila Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 153. Zydus Cadila Latest Developments

Table 154. Hikma Details, Company Type, Generic Medicine Area Served and Its Competitors

Table 155. Hikma Generic Medicine Product Offered

Table 156. Hikma Main Business

Table 157. Hikma Generic Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 158. Hikma Latest Developments

List of Figures

Figure 1. Generic Medicine Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Generic Medicine Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Generic Medicine Market Size Market Share by Type in 2021

Figure 7. Generic Medicine in CNS

Figure 8. Global Generic Medicine Market: CNS (2017-2022) & ($ Millions)

Figure 9. Generic Medicine in Cardiovascular

Figure 10. Global Generic Medicine Market: Cardiovascular (2017-2022) & ($ Millions)

Figure 11. Generic Medicine in Respiratory

Figure 12. Global Generic Medicine Market: Respiratory (2017-2022) & ($ Millions)

Figure 13. Generic Medicine in Rheumatology

Figure 14. Global Generic Medicine Market: Rheumatology (2017-2022) & ($ Millions)

Figure 15. Generic Medicine in Diabetes

Figure 16. Global Generic Medicine Market: Diabetes (2017-2022) & ($ Millions)

Figure 17. Generic Medicine in Oncology

Figure 18. Global Generic Medicine Market: Oncology (2017-2022) & ($ Millions)

Figure 19. Generic Medicine in Others

Figure 20. Global Generic Medicine Market: Others (2017-2022) & ($ Millions)

Figure 21. Global Generic Medicine Market Size Market Share by Application in 2021

Figure 22. Global Generic Medicine Revenue Market Share by Player in 2021

Figure 23. Global Generic Medicine Market Size Market Share by Regions (2017-2022)

Figure 24. Americas Generic Medicine Market Size 2017-2022 ($ Millions)

Figure 25. APAC Generic Medicine Market Size 2017-2022 ($ Millions)

Figure 26. Europe Generic Medicine Market Size 2017-2022 ($ Millions)

Figure 27. Middle East & Africa Generic Medicine Market Size 2017-2022 ($ Millions)

Figure 28. Americas Generic Medicine Value Market Share by Country in 2021

Figure 29. Americas Generic Medicine Consumption Market Share by Type in 2021

Figure 30. Americas Generic Medicine Market Size Market Share by Application in 2021

Figure 31. United States Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 32. Canada Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 33. Mexico Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 34. Brazil Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 35. APAC Generic Medicine Market Size Market Share by Region in 2021

Figure 36. APAC Generic Medicine Market Size Market Share by Application in 2021

Figure 37. China Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 38. Japan Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 39. Korea Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 40. Southeast Asia Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 41. India Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 42. Australia Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 43. Europe Generic Medicine Market Size Market Share by Country in 2021

Figure 44. Europe Generic Medicine Market Size Market Share by Type in 2021

Figure 45. Europe Generic Medicine Market Size Market Share by Application in 2021

Figure 46. Germany Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 47. France Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 48. UK Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 49. Italy Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 50. Russia Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 51. Middle East & Africa Generic Medicine Market Size Market Share by Region in 2021

Figure 52. Middle East & Africa Generic Medicine Market Size Market Share by Type in 2021

Figure 53. Middle East & Africa Generic Medicine Market Size Market Share by Application in 2021

Figure 54. Egypt Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 55. South Africa Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 56. Israel Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 57. Turkey Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 58. GCC Country Generic Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 59. Americas Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 60. APAC Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 61. Europe Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 62. Middle East & Africa Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 63. United States Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 64. Canada Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 65. Mexico Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 66. Brazil Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 67. China Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 68. Japan Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 69. Korea Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 70. Southeast Asia Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 71. India Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 72. Australia Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 73. Germany Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 74. France Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 75. UK Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 76. Italy Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 77. Russia Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 78. Spain Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 79. Egypt Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 80. South Africa Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 81. Israel Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 82. Turkey Generic Medicine Market Size 2023-2028 ($ Millions)

Figure 83. GCC Countries Generic Medicine Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390